Purcell develops reusable, smart inhalers that are medication-agnostic and designed with a patient-centric approach. These inhalers enhance medication adherence and provide real-time data to improve respiratory health management.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals with respiratory conditions struggle with medication adherence due to the complexities of using traditional inhalers and the lack of real-time feedback on their usage. This can lead to poorly managed symptoms and increased healthcare costs.
Solution
Purcell offers reusable, medication-agnostic smart inhalers designed to improve patient adherence and respiratory health management. These inhalers provide real-time data on medication usage, allowing patients and healthcare providers to track adherence and identify potential issues. By combining user-friendly design with advanced sensor technology, Purcell empowers individuals to take control of their respiratory health and optimize their treatment plans. The inhalers are compatible with a variety of medications, making them a versatile solution for different respiratory conditions.
Target Audience
Purcell's primary target audience includes individuals with asthma, COPD, and other respiratory conditions, as well as healthcare providers and respiratory therapists who manage these patients.
Features
- Reusable design reduces environmental impact and lowers long-term costs.
- Medication-agnostic compatibility allows use with various prescribed inhalers.
- Integrated sensors track inhaler usage, including dose timing and technique.
- Real-time feedback via a connected mobile app helps users improve their inhalation technique.
- Data analytics platform provides insights into patient adherence patterns for healthcare providers.